The effectiveness of NT-proBNP in diagnosing heart failure

Chinese Journal of Evidence-Based Medicine

Volumn 5, Issue 3, 2005, Pages 224-228

  Cai, Bei ^a   Wang, Lan La ^a   Liu, Jin ^a   Huang, De Jia ^a   Liu, Xing Bin ^a   Li, Li Xin ^a   Tang, Jiang Tao ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Diagnostic test; Heart failure; NT proBNP

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ARTICLE; CHEMOLUMINESCENCE; CONGESTIVE CARDIOMYOPATHY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DISEASE SEVERITY; EVALUATION; HEART FAILURE; HUMAN; HYPERTENSION; IMMUNOASSAY; ISCHEMIC HEART DISEASE; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; RELIABILITY; SENSITIVITY AND SPECIFICITY;

EID: 20044375916     PISSN: 16722531     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Berendes E, Schmidt C, Van Aken H, Hartlage MG, Rothenburger M, Wirtz S, Scheld HH, Brodner G, Walter M. A-type and B-type natriuretic peptides in cardiac surgical procedures [J]. Anesth Analg, 2004; 98(1): 11-19.
2. Mair J, Hammerer-Lercher A, Puschendorf B. The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure[J]. Clin Chem Lab Med, 2001; 39(7): 571-588.
3. Mueller T, Gegenhuber A, Poelz W, Haltmayer M. Biochemical diagnosis of impaired left ventricular ejection fraction-comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and amino terminal proBNP (NT-proBNP) [J]. Clin Chem Lab Med, 2004; 42 (2): 159-163.
4. Meune C, Martins E, Fulla Y, Bergmann JF, Devaux JY, Mourad JJ, New biological markers for acute coronary artery disease [J]. J Mal Vase, 2003; 28(5): 251-257.
5. Prontera C, Emdin M, Zucchelli GC, Ripoli A, Passino C, Clerico A. Analytical performance and diagnostic accuracy of a fully-automated electrochemiluminescent assay for the N-terminal fragment of the propeptide of brain natriuretic peptide in patients with cardiomyopathy: comparison with immunoradiometric assay methods for brain natriuretic peptide and atrial natriuretic peptide[J]. Clin Chem Lab Med, 2004; 42(1): 37-44.
6. Pfister R, Scholz M, Wielckens K, Erdmann E, Schneider CA. Use of NT-proBNP in routine testing and comparison to BNP[J]. Eur J Heart Fail, 2004; 6(3): 289-293.
7. Vanderheyden M, Bartunek J, Goethals M. Brain and other natriuretic peptides: molecular aspects[J]. Eur J Heart Fail, 2004; 6(3): 261-268.
8. Richards AM, Doughty R, Nicholls MG, MacMahon S, Sharpe N, Murphy J, Espiner EA, Frampton C, Yandle TG; Australia-New Zealand Heart Failure Group. Plasma N-terminal pro-brain natnuretic peptide and adrenomedullin: prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure Group[J]. J Am Coll Cardiol, 2001; 37(7): 1 781-1 787.
9. Wu X, Seino Y, Ogura H, Fukuma N, Katoh T, Takano T. Plasma natnuretic peptide levels and daily physical activity in patients with pacemaker implantation[J]. Jpn Heart J, 2001; 42(4): 471-482.
10. Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, Omland T, Storrow AB, Abraham WT, Wu AH, Clopton P, Steg PG, Westheim A, Knudsen CW, Perez A, Kazanegra R, Herrmann HC, McCullough PA; Breathing Not Properly Multinational Study Investigators. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure[J]. N Engl J Med, 2002; 347(3): 161-167.
11. McCullough PA, Nowak RM, McCord J, Hollander JE, Herrmann HC, Steg PG, Duc P, Westheim A, Omland T, Knudsen CW, Storrow AB, Abraham WT, Lamba S, Wu AH, Perez A, Clopton P, Krishnaswamy P, Kazanegra R, Maisel AS. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study[J]. Circulation, 2002; 106(4): 416-422.
12. Bay M, Kirk V, Parner J, Hassager C, Nielsen H, Krogsgaard K, Trawinski J, Boesgaard S, Aldershvile J. NT-proBNP: a new diagnostic screening tool to differentiate between patients with normal and reduced left ventricular systolic function[J]. Heart, 2003; 89 (2): 150-154.
13. Omland T, Persson A, Ng L, O'Brien R, Karlsson T, Herlitz J, Hartford M, Caidahl K. N-terminal pro-B-type natnuretic peptide and long-term mortality in acute coronary syndromes[J]. Circulation, 2002; 106(23): 2 913-2 918.
14. Jernberg T, Stridsberg M, Venge P, Lindahl B. N-terminal pro brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation[J]. J Am Coll Cardiol, 2002; 40(3): 437-445.